02-10-2023 01:20 PM | Source: Sushil Finance
Buy Kilitch Drugs (India) Ltd For Target Rs.254 - Sushil Finance
We have coverage on Kilitch Drugs (India) Ltd with a BUY rating on stock. Since our report, the stock has posted a high of Rs.244 today
With the recent run-up in the share price (36% return), we are now changing our rating on the stock to Neutral and recommend our investors to book profits.
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
To Read Complete Report & Disclaimer
Click Here
Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer
Latest News
Market Watch: Equities rise, but US Jobs data eyed -...
Indian banks` loans rose 19% year-on-year in two we...
HFCL delivers resilient performance led by innovatio...
Tata Technologies clocks profit before tax at Rs 932...
Sensex falls 732 points on profit booking
Evening Roundup : A Daily Report on Bullion Energy &...
Indian jeweller Titan misses Q4 profit view as gold ...
BJP candidate Agnimitra Paul offers prayers at Ram M...
I think it is a perfect team: Rajeev Shukla on India...
FIIs stood as net sellers in equities as per May 03 ...